This is a Validated Antibody Database (VAD) review about human RCN2, based on 2 published articles (read how Labome selects the articles), using RCN2 antibody in all methods. It is aimed to help Labome visitors find the most suited RCN2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RCN2 synonym: E6BP; ERC-55; ERC55; TCBP49; reticulocalbin-2; E6-binding protein; calcium-binding protein ERC-55; reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD)

Proteintech Group
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:3000; fig 3
Proteintech Group RCN2 antibody (Proteintech, 10193-2-AP) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:3000 (fig 3). Int J Oncol (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:200; fig 3b
In order to use mouse models to discover mechanisms that lead to LGI1-related epilepsy, Proteintech Group RCN2 antibody (Protein Tech, 10193-2) was used in western blot on mouse samples at 1:200 (fig 3b). Nat Med (2015) ncbi
Articles Reviewed
  1. Nakakido M, Tamura K, Chung S, Ueda K, Fujii R, Kiyotani K, et al. Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors. Int J Oncol. 2016;49:868-76 pubmed publisher
  2. Yokoi N, Fukata Y, Kase D, Miyazaki T, Jaegle M, Ohkawa T, et al. Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy. Nat Med. 2015;21:19-26 pubmed publisher